When Dr. Rotem Gross first noticed something strange in his lab at the University of Cologne, he couldn't quite believe it. A petri dish of E. coli bacteria— germs that cause urinary tract infections and dangerous hospital-acquired illnesses—had been exposed to antibiotics. At first, the bacteria died off. But then, remarkably, they bounced back. The culture recovered and kept on growing, completely unhindered.
Curious about this resurrection, Gross teamed up with colleagues at the Institute for Biological Physics at the University of Cologne and at Wageningen University & Research in the Netherlands. Their discovery, published in the journal Proceedings of the National Academy of Sciences, reveals a surprising survival tactic: bacteria can destroy antibiotics by releasing enzymes from their dying cells.
The researchers studied two strains of E. coli and how they responded to beta-lactams, the most widely used class of antibiotics worldwide. What they found was striking. The bacteria produce an enzyme called beta-lactamase, which chemically breaks down the antibiotic before it can do harm. While living bacteria keep the enzyme inside their cells to neutralize antibiotics they've absorbed, dying bacteria release it into their surroundings—creating a protective shield for the entire community.
"The death of some of the bacteria contributes significantly to the long-term survival of the population as a whole," said Dr. Joachim Krug, one of the study's leaders in Cologne. He calls this behavior "altruistic cell death."
The team discovered that once the antibiotic concentration drops below a certain threshold—thanks to all that enzymatic cleanup— the surviving bacteria begin multiplying again. The two strains studied showed different levels of this sacrificial behavior, which means they may also respond differently to drugs called beta-lactamase inhibitors, which are already used in hospitals to treat infections.
Here is the hopeful part: the researchers found that bacteria with higher levels of altruistic cell death are actually more vulnerable to these inhibitor drugs. That means understanding this mechanism could help scientists design better antibiotic treatments that work with the bacteria's own defenses.
"We were amazed by the variety of defense mechanisms that the bacteria are able to mobilize even under simple laboratory conditions," Krug said. Predicting exactly how antibiotics will work in real human bodies remains a challenge, but it's one his team plans to tackle next. Their work suggests that sometimes, to beat an enemy, you first have to understand how it protects itself.